Technology capabilities of the group:
-Design and production of proteins for biotechnological, biomedical and nanotechnological applications.
-Development of functional materials based on functional proteins for applications in drug and vaccine design, diagnostics and targeted therapies.
Group patents with the possibility of being licensed:
- Systems for sustained release of protein drugs, nanoparticles and functional proteins, in cosmetics and therapy (PCT / EP2018 / 069303).
Interest in finding industrial partners for:
- Development of sustained release systems of proteins and nanomaterials for cosmetics and therapy.
Interest in participating as partners in projects:
European and International Projects:
- Production of functional proteins and protein materials. Drug design for targeted protein-based therapies.
Collaboration with industry:
- Production of recombinant proteins in different expression systems.
- Development of protein-based sustained release systems for cosmetics, vaccination, diagnosis and therapy.
Acronym | CIBER BBN |
---|
Status | Active |
---|
Effective start/end date | 1/01/09 → 31/12/30 |
---|
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):